[vc_row][vc_column width=”1/2″][vc_column_text]
Kirrhos Pharmaceuticals is focused on developing an orally available, small molecule inhibitor for the treatment of non-alcoholic steatohepatitis.[/vc_column_text][/vc_column][vc_column width=”1/4″][rd_vline color=”#1e73be”][/vc_column][vc_column width=”1/4″][vc_column_text]Year Founded: 2019
Year Partnered: 2019
Category: BioTech/Pharma
Fund: Oklahoma Accelerate Fund
Press Release: Kirrhos Link
www.ascendbioventures.com/portfolio/[/vc_column_text][/vc_column][/vc_row]